The purpose of this study is to demonstrate the safety and efficacy of the corneal collagen crosslinking with riboflavin and ultraviolet A in aim to increase the resistance of the graft used as a support for the Boston keratoprosthesis (KPro) type I against corneal melting (keratolysis or sterile necrosis).
Candidate for KPro type I
Capacity to give written consent
Ability to be followed for the duration of the study
Participation in another interventional study
Failure to wear a therapeutic contact lens due to abnormalities of the eyelids.
Inability to give written consent
Severe dryness with keratinization of the ocular surface
Centre hospitalier de l'Université de Montréal (CHUM)
Lead sponsor
Maisonneuve-Rosemont Hospital
Collaborator